Heron Therapeutics signs 10-year US license deal with Long Grove Pharmaceuticals

Heron Therapeutics entered a multi-product development and license agreement with Long Grove Pharmaceuticals granting an exclusive, sublicensable US license; Long Grove gets milestones and royalties, and Heron receives a non-exclusive worldwide manufacturing license for US-sold products.